Extracorporeal Shock Wave Therapy with Imaging Examination for Early Osteonecrosis of the Femoral Head: a Systematic Review

Overview

Journal Int J Surg

Specialty General Surgery

Date 2024 Jun 19

PMID 38896858

Authors

Han Tan

Peiyuan Tang

Hua Chai

Wenbo Ma

Yangbin Cao

Bin Lin

Ying Zhu

Wenfeng Xiao

Ting Wen

Yusheng Li

Affiliations

Soon will be listed here.

Abstract

Background: Extracorporeal shockwave therapy (ESWT) is a traditional noninvasive therapy to treat osteonecrosis of the femur head (ONFH). This systematic review aims to investigate whether ESWT can improve the clinical function of ONFH and whether differences in improvement can be observed in radiographic outcomes.

Materials And Methods: Two authors independently searched PubMed, Embase, Cochrane Library, and Web of Science for English articles until 21 October 2023. After screening and reading the literature, the two authors independently used corresponding scales to evaluate the quality of the included articles and extracted data. The key data extracted included the Harris Hip Score (HHS), Visual Analog Scale (VAS), changes in lesion size, the change in the Association Research Circulation Osseous (ARCO) stage, and bone marrow edema (BME) stage.

Results: Nine articles included 468 males and 248 females. The average age was 43.29 years and the mean follow-up time was 15.19 months. After receiving ESWT, five studies involving 146 hips showed a higher HHS (MD=-33.38; 95% CI: -46.31, -20.45), and the difference was statistically significant ( P <0.00001). The average VAS before treatment was above 5, but it dropped to 1.2 after ESWT (MD=4.64; 95% CI: 3.63-5.64), and the difference was statistically significant ( P <0.00001). Three studies found no significant differences in the areas of femoral head necrosis before and after treatment with ESWT(MD=9.66; 95% CI: -0.36, 19.67; P =0.06; I2 =84%). Two articles showed that the use of ESWT had no significant effect on the change in the ARCO stage (MD=1.11; 95% CI: 0.76-1.62; P =0.60; I2 =0%). Three studies indicated that using ESWT could improve the BME symptom in the early stage of ONFH (MD=4.35; 95% CI: 1.32-14.37; P =0.02; I2 =62%).

Conclusion: Based on the current evidence, ESWT shows promise as a therapy to enhance hip function and alleviate pain in the early stage of ONFH. With the advancement of more precise imaging techniques, ESWT can potentially reduce the area affected by ONFH. However, such reduction was not found to be statistically significant at the imaging level. Additionally, ESWT could improve symptoms of BME in the early stage. However, no significant change in ARCO grade was observed with ESWT treatment.

Citing Articles

Effects of supplementing extracorporeal shockwave therapy to hyaluronic acid injection among patients with rotator cuff lesions without complete tear: a prospective double-blinded randomized study.

Ko J, Huang C, Huang P, Chen J, Liao C, Kuo S Int J Surg. 2024; 110(12):7421-7433.

PMID: 39172722 PMC: 11634091. DOI: 10.1097/JS9.0000000000002063.

References

Wang C, Wang F, Yang K, Huang C, Lee M, Chan Y . Treatment of osteonecrosis of the hip: comparison of extracorporeal shockwave with shockwave and alendronate. Arch Orthop Trauma Surg. 2007; 128(9):901-8. DOI: 10.1007/s00402-007-0530-5. View

Wang C, Huang H . Shock wave-enhanced neovascularization at the tendon-bone junction: an experiment in dogs. J Foot Ankle Surg. 2002; 41(1):16-22. DOI: 10.1016/s1067-2516(02)80005-9. View

Abbassi M, Jain A, Shin D, Arasa C, Li B, Anderson S . Quantification of bone marrow edema using dual-energy CT at fracture sites in trauma. Emerg Radiol. 2022; 29(4):691-696. DOI: 10.1007/s10140-022-02046-0. View

Vulpiani M, Vetrano M, Trischitta D, Scarcello L, Chizzi F, Argento G . Extracorporeal shock wave therapy in early osteonecrosis of the femoral head: prospective clinical study with long-term follow-up. Arch Orthop Trauma Surg. 2012; 132(4):499-508. DOI: 10.1007/s00402-011-1444-9. View

Mankin H . Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med. 1992; 326(22):1473-9. DOI: 10.1056/NEJM199205283262206. View

Hopkins C, Genant H . Editorial for Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version). J Orthop Translat. 2020; 21:A1. PMC: 7152789. DOI: 10.1016/j.jot.2020.01.009. View

Wang C, Wang F, Huang C, Yang K, Weng L, Huang H . Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting. J Bone Joint Surg Am. 2005; 87(11):2380-7. DOI: 10.2106/JBJS.E.00174. View

Hofmann S . The painful bone marrow edema syndrome of the hip joint. Wien Klin Wochenschr. 2005; 117(4):111-20. DOI: 10.1007/s00508-005-0322-2. View

Wang C, Huang C, Yip H, Yang Y . Dosage effects of extracorporeal shockwave therapy in early hip necrosis. Int J Surg. 2016; 35:179-186. DOI: 10.1016/j.ijsu.2016.09.013. View

10.

Rassweiler J, Knoll T, Kohrmann K, McAteer J, Lingeman J, Cleveland R . Shock wave technology and application: an update. Eur Urol. 2011; 59(5):784-96. PMC: 3319085. DOI: 10.1016/j.eururo.2011.02.033. View

11.

Ma H, Zeng B, Li X . Upregulation of VEGF in subchondral bone of necrotic femoral heads in rabbits with use of extracorporeal shock waves. Calcif Tissue Int. 2007; 81(2):124-31. DOI: 10.1007/s00223-007-9046-9. View

12.

Gao F, Sun W, Li Z, Guo W, Wang W, Cheng L . High-Energy Extracorporeal Shock Wave for Early Stage Osteonecrosis of the Femoral Head: A Single-Center Case Series. Evid Based Complement Alternat Med. 2015; 2015:468090. PMC: 4644843. DOI: 10.1155/2015/468090. View

13.

Learmonth I, Maloon S, Dall G . Core decompression for early atraumatic osteonecrosis of the femoral head. J Bone Joint Surg Br. 1990; 72(3):387-90. DOI: 10.1302/0301-620X.72B3.2341433. View

14.

Vande Berg B, Malghem J, Lecouvet F, Jamart J, Maldague B . Idiopathic bone marrow edema lesions of the femoral head: predictive value of MR imaging findings. Radiology. 1999; 212(2):527-35. DOI: 10.1148/radiology.212.2.r99au03527. View

15.

Wu M, Jia D, Yu H, Liu Y, Li J, Zhang Y . Application of double-layer detector spectral CT calcicum supression technique in the diagnosis of traumatic bone marrow edema in the knee. Heliyon. 2023; 9(10):e20758. PMC: 10582395. DOI: 10.1016/j.heliyon.2023.e20758. View

16.

Wang C, Huang C, Wang J, Wong T, Yang Y . Long-term results of extracorporeal shockwave therapy and core decompression in osteonecrosis of the femoral head with eight- to nine-year follow-up. Biomed J. 2013; 35(6):481-5. DOI: 10.4103/2319-4170.104413. View

17.

Wang C, Cheng J, Huang C, Yip H, Russo S . Extracorporeal shockwave therapy for avascular necrosis of femoral head. Int J Surg. 2015; 24(Pt B):184-7. DOI: 10.1016/j.ijsu.2015.06.080. View

18.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

19.

Zhu J, Yan J, Xiao J, Jia H, Liang H, Xing G . Effects of individual shock wave therapy celecoxib on hip pain caused by femoral head necrosis. World J Clin Cases. 2023; 11(9):1974-1984. PMC: 10044968. DOI: 10.12998/wjcc.v11.i9.1974. View

20.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View